The IMB Inflazome Translational Award recognises an outstanding IMB researcher working on a project with translational potential. The Award provides $125,000 over one year to accelerate the winner's translational research to enable future competitive funding success, commercialisation or community impact.
Solar biotechnologies are being designed to expand Australian advanced manufacture, from next-generation COVID therapeutics through to renewable fuels.
Better medicines, food, nutraceuticals, nanomaterials and biofertilisers will flow from new Australian Government funding to bolster marine bioproduct innovation.
